BW VACCINE SURGE MEETING 3 DEC 90

File: 120396_sep96_decls63_0001.txt
Page: 0001
Total Pages: 3

Subject: BW VACCINE SURGE MEETING  3 DEC 90                              

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: BW VACCINE SURGE MEETING                                                                        

Document Number:          1

Folder SEQ  #:         15







                                                UNCLASSIFIED 'ODEC 19,10


          DASG-PSZ



          MEMORANDUM FOR RECORD

          SUBJECT: BW VACCINE SURGE MEETING
          1. Reference memorandum from ASD(HA) to Secretary of the Army
          dated 10 November 90, subject: Expansion of Industrial Base for
          Biological vaccine Production

          2. A meeting was held with representatives from the Office of
          the Surgeon General and Medical Research and Development Command
          to act on the memorandum from ASD(RA). The attendees are listed
          at Enclosure 1.

          3. Each directive in the ASD(HA) memorandum was addressed
          separately with specific attention to timeliness, potential
          problems in funding. The following summary is provided:
               a. Michigan Public Health Service (Production Increase).
          This group is currently under contract to produce anthrax vaccine and
          now has two additional fermenters (totaling three) so that they can
          potentially produce                   vaccine every six weeks.
          The FDA will however not license them until tests of the new
          fermenters are completed. This should occur by 1 February 1991 at
          which time they can begin full production. Funding is already
          written into the new contract and no additional monies are
          needed at this time.

               b                                    The company has one 300
          liter iermenter in an old facility, however the fermenter has
          been well maintained.    They need FDA approval, vaccination for
          their personnel and a letter contract from us to begin
          production. We will provide the letter contract with start up
          funds of $150,000 immediately and they will begin facility
          opening, personnel vaccination, etc. They should be able to
          start up six weeks from now with appropriate FDA approval and
 available approximately by the middle
          to late March.


                                                                 This group
          has six 200 liter fermenterb in an old facility with    renovation
          and FDA Inspection and approval required. Vaccination of
          personnel is also necessary. They are hiring personnel now and
          need six weeks to begin production and to acquire the appropriate
          levels of antibody production and approvals. Start up costs are
          $200,000.          DECLASSIFIED
                             ON: 15 NOV 96
                             BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958


                 UNCLASSIFIED

Document 3 f:/Week-36/BX003203/BW VACCINE SURGE MEETING/bw vaccine surge meeting 3 dec 90:1125961012453
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BW VACCINE SURGE MEETING
Folder Seq # = 15
Subject = BW VACCINE SURGE MEETING 3 DEC 90
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-NOV-1996